BioRestorative Therapies, Inc. (BRTX)

NASDAQ: BRTX · Real-Time Price · USD

0.223

-0.010 (-4.21%)

At close: Apr 28, 2026, 4:00 PM EDT

0.224

+0.001 (0.27%)

After-hours: Apr 28, 2026, 6:08 PM EDT

BioRestorative Therapies Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for BioRestorative Therapies.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for BioRestorative Therapies.

Recommendation Trends

Rating	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	2	2	2	1	1
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Maintains $15 → $18	Strong Buy	Maintains	$15 → $18	+7,975.37%	Aug 14, 2024
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Maintains $15	Strong Buy	Maintains	$15	+6,629.48%	Jun 12, 2024
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Reiterates $15	Strong Buy	Reiterates	$15	+6,629.48%	Aug 14, 2023
Jonathan Aschoff Roth Capital	Roth Capital	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+6,629.48%	Dec 7, 2022
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+2,591.79%	Sep 28, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

1.43M

from 359.70K

298.39%

from 359.70K

Revenue Next Year

2.36M

from 1.43M

64.62%

from 1.43M

EPS This Year

-0.77

from -1.58

EPS Next Year

-0.41

from -0.77

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	46.00K	119.80K	145.80K	401.00K	359.70K	1.43M	2.36M
Revenue Growth	-40.26%	160.44%	21.70%	175.03%	-10.30%	298.39%	64.62%
EPS	-37.30	-3.65	-2.47	-1.16	-1.58	-0.77	-0.41
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	2.6M	3.3M
Avg	1.4M	2.4M
Low	303,800	1.5M

Revenue Growth

Revenue Growth	2026	2027
High	629.8%	129.0%
Avg	298.4%	64.6%
Low	-15.5%	2.6%

EPS Forecast

EPS	2026	2027
High	-0.35	-0.30
Avg	-0.77	-0.41
Low	-1.15	-0.51

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.